Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-based pharmacogenetics and the pharmaceutical industry.

Nature reviews. Drug discovery - 1 Jul 2002

Roses Allen D

Abstract excerpt

Pharmacogenetic capabilities have changed markedly since The SNP Consortium made a dense single-nucleotide polymorphism (SNP) map freely available in 2001. For more than 40 years, pharmacokinetics and pharmacodynamics of drug-metabolizing molecules were the focus of practical applications. Today, it is possible to use SNP-mapping technologies to create a genetic profile of each individual that can be used to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Dideoxynucleosides
Share to Drug Industry

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genome

Share to Pharmacogenetics

Share to Polymorphism, Single Nucleotide

Share to Proteome

Source

Identifiers

PMID: 12120260
DOI: 10.1038/nrd840

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-based pharmacogenetics and the pharmaceutical industry.PMID 12120260Read ↗

Pharmacogenetics and pharmacogenomicsSemantic proximity Read ↗

[SNP collection, pharmacogenomics, and the future of drug therapy].Semantic proximity Read ↗

Pharmacogenomics: historical perspective and current status.Semantic proximity Read ↗

Pharmacogenetics: An Important Part of Drug Development with A Focus on Its ApplicationSemantic proximity Read ↗

The use of single-nucleotide polymorphism maps in pharmacogenomics.Semantic proximity Read ↗

A SNPshot: pharmacogenetics and the future of drug therapy.Semantic proximity Read ↗

SNP technologies for drug discovery: a current review.Semantic proximity Read ↗

Pharmacogenomics: An evolving clinical tool for precision medicine.Semantic proximity Read ↗

Pharmacogenomics: Current State-of-the-ArtSemantic proximity Read ↗

HapMap, pharmacogenomics, and the goal of personalized prescribing.Semantic proximity Read ↗

SNP discovery and typing technologies for pharmacogenomics.Semantic proximity Read ↗

Progress towards the integration of pharmacogenomics in practice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.